Phase 2 Trial of Total Mucosal and Bilateral Neck Intensity Modulated Radiotherapy in Squamous Cell Cancer of Unknown Primary

被引：2
|
作者：
Richards, T. M. [1 ]
Bhide, S. A. [1 ]
Miah, A. B. [1 ]
Schick, U. [1 ]
Gujral, D. M. [1 ]
Newbold, K. [1 ]
Harrington, K. J. [1 ]
Nutting, C. M. [1 ]
机构：
[1] Royal Marsden Hosp, Head & Neck Unit, London SW3 6JJ, England
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72194-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S559 / S559
页数：1
相关论文
共 50 条
  • [31] RADIOTHERAPY AND CISPLATIN IN METASTATIC SQUAMOUS-CELL CARCINOMA OF AN UNKNOWN PRIMARY TUMOR LOCALIZED TO THE NECK - A PHASE-II STUDY
    JEREMIC, B
    ZIVIC, L
    JEVREMOVIC, S
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (06) : 399 - 402
  • [32] Re-irradiation with Intensity Modulated Radiotherapy for recurrent or second primary head and neck cancer
    Travancinha, C.
    Labareda, M.
    Pocinho, R.
    Netto, E.
    Antunes, T.
    Roldao, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S28 - S28
  • [33] Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial
    Nutting, Christopher
    Finneran, Laura
    Roe, Justin
    Sydenham, Mark A.
    Beasley, Matthew
    Bhide, Shree
    Boon, Cheng
    Cook, Audrey
    De Winton, Emma
    Emson, Marie
    Foran, Bernadette
    Frogley, Robert
    Petkar, Imran
    Pettit, Laura
    Rooney, Keith
    Roques, Tom
    Srinivasan, Devraj
    Tyler, Justine
    DARS Trialist Grp
    LANCET ONCOLOGY, 2023, 24 (08): : 868 - 880
  • [34] Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial
    Ashour, May Gamal
    Shouman, Tarek Hamed
    Hassouna, Ashraf Hamed
    Mokhtar, Maha Hassan
    El Din, Reem Emad
    Youssef, Ayda Aly
    Gomaa, Mohammed Mohammed
    Abdelgeleel, Shaimaa
    ACTA ONCOLOGICA, 2022, 61 (02) : 134 - 140
  • [35] Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma
    Yao, Min
    Woods, Charles
    Lavertu, Pierre
    Fu, Pingfu
    Gibson, Michael
    Rezaee, Rod
    Zender, Chad
    Wasman, Jay
    Sharma, Neelesh
    Machtay, Mitchell
    Savvides, Panayiotis
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1770 - E1776
  • [36] Five-year follow-up for head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy
    Dutta, S. W.
    Bliley, R. C.
    Luminais, C.
    Read, P. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1139 - 1139
  • [37] NIMRAD - A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer
    Thomson, D.
    Yang, H.
    Baines, H.
    Miles, E.
    Bolton, S.
    West, C.
    Slevin, N.
    CLINICAL ONCOLOGY, 2014, 26 (06) : 344 - 347
  • [38] HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer
    Schroeder, Lea
    Pring, Miranda
    Ingarfield, Kate
    Pawlita, Michael
    Leary, Sam D.
    Thomas, Steve J.
    Waylen, Andrea
    Waterboer, Tim
    Ness, Andy R.
    ORAL ONCOLOGY, 2020, 107
  • [39] The Impact of FDG PET/CT in the Management of the Unknown Squamous Cell Cancer Primary in the Head and Neck: Results of a Prospective Trial
    Nasoodi, A.
    McCaul, D.
    Fahy, C.
    Primrose, W.
    Ullah, R.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [40] Transoral robotic surgery in the management of head and neck squamous cell cancer with unknown primary
    Nilsson, Johan S.
    Wahlberg, Peter
    Greiff, Lennart
    ACTA OTO-LARYNGOLOGICA, 2020, 140 (01) : 85 - 88
12345